Envisagenics is a biotechnology company specializing in RNA splicing analytics and drug discovery. The company leverages its proprietary AI-driven platform, SpliceCore®, to identify potential therapeutic targets for various diseases by analyzing large-scale RNA sequencing data. Envisagenics aims to accelerate the development of RNA-targeted therapies and collaborates with pharmaceutical companies, research institutions, and academic partners to advance the understanding and treatment of genetic disorders.